Case Study: GSK standardizes global site collaboration with Veeva Site Connect
Key results
The challenge
GSK works with thousands of clinical research sites and had relied on fragmented, sponsor-specific legacy tools to manage those relationships. The lack of a unified, sponsor-agnostic system made site collaboration and safety-document distribution difficult to standardize at global scale.
The solution
GSK deployed Veeva Site Connect to replace fragmented legacy tools with a single, sponsor-agnostic platform for site collaboration. The system standardized how the company onboards sites and exchanges documents and safety information across its global study footprint.
The results, in context
GSK onboarded 8,600 sites globally onto the unified platform and doubled the number of active site users. The company also recorded a 42% improvement in safety letter compliance after consolidating site collaboration on Veeva Site Connect.